81731-43-3 Usage
Uses
Used in Pharmaceutical Industry:
2-Isopropoxy-ethylamine is used as an intermediate for the synthesis of various pharmaceuticals, contributing to the development of new drugs and improving the efficacy of existing ones.
Used in Agricultural Chemicals Production:
2-Isopropoxy-ethylamine is utilized as an intermediate in the production of agricultural chemicals, playing a crucial role in the synthesis of pesticides and other agrochemicals to enhance crop protection and yield.
Used as a Catalyst in Organic Synthesis:
2-Isopropoxy-ethylamine functions as a catalyst in various organic synthesis processes, facilitating and accelerating chemical reactions, which is vital for the production of a wide array of chemical products.
Used as a Solvent in Chemical and Pharmaceutical Industries:
Due to its solubility properties, 2-Isopropoxy-ethylamine is employed as a solvent in both the chemical and pharmaceutical sectors, aiding in the dissolution and processing of various substances.
Used in Surfactant and Cleaning Product Manufacturing:
2-Isopropoxy-ethylamine has potential applications in the production of surfactants and cleaning products, where it can enhance the effectiveness of these products in cleaning and emulsifying processes.
Used as a Reagent in Organic Reactions:
2-Isopropoxy-ethylamine is also used as a reagent in a variety of organic reactions, further highlighting its importance as a building block in the synthesis of numerous chemical products.
Check Digit Verification of cas no
The CAS Registry Mumber 81731-43-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 8,1,7,3 and 1 respectively; the second part has 2 digits, 4 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 81731-43:
(7*8)+(6*1)+(5*7)+(4*3)+(3*1)+(2*4)+(1*3)=123
123 % 10 = 3
So 81731-43-3 is a valid CAS Registry Number.
81731-43-3Relevant academic research and scientific papers
HIV INTEGRASE INHIBITORS
-
, (2015/09/22)
The present invention features compounds that are HIV integrase inhibitors and therefore are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC.
